Sanofi floats flu shot marketing pledges to pacify EU antitrust probe on July 09, 2026 antitrust probe Commission commitments competition EU Fluad antitrust preliminary assessment sanofi Sanofi Efluelda flu Sanofi flu Seqirus shot marketing SMPX gene vaccine marketing Vaccines +
EU investigates Sanofi over alleged smear campaign against rival flu vaccine Fluad on June 26, 2026 Antitrust Probe Commission competition rules disparagement Efluelda EU Fluad France Germany sanofi Seqirus SMPX gene +
CSL Announces CEO Retirement and Interim Appointment Amid Upcoming Earnings on February 11, 2026 CEO Gordon Interim Paul McKenzie Retirement Seqirus SMPX gene +
CSL Announces Vaccine Unit Spin-Off and Major Workforce Cuts on August 20, 2025 cost-cutting demerger Seqirus SMPX gene strategic restructuring Vaccines +
HHS ousts MAHA implementation lead amid rushed cancellations of $500M in mRNA vaccine contracts on August 11, 2025 BARDA CHARGE Syndrome Contract agreement Gray Delany MAHA Moderna mRNA contracts Pfizer Policy Robert F. Kennedy Seqirus Shakeup SMPX gene Staff terminations Vaccines +
HHS Cancels $500 Million in BARDA-Funded mRNA Vaccine Contracts Amid Strategic Shift on August 07, 2025 BARDA CHARGE Syndrome contract cancellation COVID19 (disease) development aspects federal funding Moderna mRNA Vaccine Pfizer Robert F. Kennedy Jr. Seqirus Vaccines +